XPC Antibodies

Santa Cruz Biotechnology features a diverse variety of XPC monoclonal antibodies for the detection and analysis of XPC protein, a crucial component of the nucleotide excision repair (NER) pathway. XPC monoclonal antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). XPC protein plays a vital role in recognizing and initiating the repair of DNA damage caused by environmental factors such as UV radiation and chemical exposure. Proper XPC function is essential for maintaining genomic stability and preventing mutations that can lead to cancer. Understanding XPC activity helps researchers explore cellular responses to DNA damage and potential therapeutic interventions. XPC research contributes significantly to our knowledge of cancer development and progression. Investigating XPC mechanisms provides insights into DNA repair pathways and their role in disease prevention. Research using XPC monoclonal antibodies advances scientific understanding of DNA repair processes and supports the development of new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for XPC enable researchers worldwide to advance scientific understanding of DNA repair mechanisms and their impact on human health.